vs
Side-by-side financial comparison of Protalix BioTherapeutics, Inc. (PLX) and Stabilis Solutions, Inc. (SLNG). Click either name above to swap in a different company.
Stabilis Solutions, Inc. is the larger business by last-quarter revenue ($13.3M vs $9.1M, roughly 1.5× Protalix BioTherapeutics, Inc.). Stabilis Solutions, Inc. runs the higher net margin — -2.0% vs -60.3%, a 58.4% gap on every dollar of revenue. On growth, Stabilis Solutions, Inc. posted the faster year-over-year revenue change (-23.3% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-2.5M). Over the past eight quarters, Protalix BioTherapeutics, Inc.'s revenue compounded faster (-6.7% CAGR vs -18.1%).
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
Stabilis Solutions, Inc.SLNGEarnings & Financial Report
Stabilis Solutions, Inc. is a leading North American small-scale liquefied natural gas (LNG) producer and distributor. It supplies LNG fuel, cryogenic services, and full-cycle energy solutions to industrial, remote power, transportation, and commercial clients across the United States and Canada, advancing low-emission energy transition efforts.
PLX vs SLNG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.1M | $13.3M |
| Net Profit | $-5.5M | $-262.0K |
| Gross Margin | 49.4% | 24.7% |
| Operating Margin | -51.1% | -2.4% |
| Net Margin | -60.3% | -2.0% |
| Revenue YoY | -49.9% | -23.3% |
| Net Profit YoY | -184.8% | -112.4% |
| EPS (diluted) | $-0.06 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.1M | $13.3M | ||
| Q3 25 | $17.9M | $20.3M | ||
| Q2 25 | $15.7M | $17.3M | ||
| Q1 25 | $10.1M | $17.3M | ||
| Q4 24 | $18.2M | $17.3M | ||
| Q3 24 | $18.0M | $17.6M | ||
| Q2 24 | $13.5M | $18.6M | ||
| Q1 24 | — | $19.8M |
| Q4 25 | $-5.5M | $-262.0K | ||
| Q3 25 | $2.4M | $1.1M | ||
| Q2 25 | $164.0K | $-613.0K | ||
| Q1 25 | $-3.6M | $-1.6M | ||
| Q4 24 | $6.5M | $2.1M | ||
| Q3 24 | $3.2M | $997.0K | ||
| Q2 24 | $-2.2M | $27.0K | ||
| Q1 24 | — | $1.5M |
| Q4 25 | 49.4% | 24.7% | ||
| Q3 25 | 53.4% | 27.6% | ||
| Q2 25 | 62.5% | 26.5% | ||
| Q1 25 | 19.1% | 26.2% | ||
| Q4 24 | 78.7% | 28.5% | ||
| Q3 24 | 53.4% | 28.3% | ||
| Q2 24 | 29.8% | 27.1% | ||
| Q1 24 | — | 31.6% |
| Q4 25 | -51.1% | -2.4% | ||
| Q3 25 | 11.9% | 5.5% | ||
| Q2 25 | 7.5% | -2.4% | ||
| Q1 25 | -41.0% | -9.7% | ||
| Q4 24 | 39.6% | 12.8% | ||
| Q3 24 | 22.2% | 5.0% | ||
| Q2 24 | -18.0% | 2.4% | ||
| Q1 24 | — | 7.8% |
| Q4 25 | -60.3% | -2.0% | ||
| Q3 25 | 13.2% | 5.5% | ||
| Q2 25 | 1.0% | -3.5% | ||
| Q1 25 | -35.8% | -9.2% | ||
| Q4 24 | 35.6% | 12.2% | ||
| Q3 24 | 18.0% | 5.7% | ||
| Q2 24 | -16.4% | 0.1% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | $0.06 | ||
| Q2 25 | $0.00 | $-0.03 | ||
| Q1 25 | $-0.05 | $-0.09 | ||
| Q4 24 | $0.10 | $0.12 | ||
| Q3 24 | $0.03 | $0.05 | ||
| Q2 24 | $-0.03 | $0.00 | ||
| Q1 24 | — | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.7M | $7.5M |
| Total DebtLower is stronger | — | $7.9M |
| Stockholders' EquityBook value | $48.2M | $66.7M |
| Total Assets | $82.3M | $83.1M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.7M | $7.5M | ||
| Q3 25 | $13.6M | $10.3M | ||
| Q2 25 | $17.9M | $12.2M | ||
| Q1 25 | $19.5M | $9.0M | ||
| Q4 24 | $19.8M | $9.0M | ||
| Q3 24 | $27.4M | $12.4M | ||
| Q2 24 | $23.4M | $11.5M | ||
| Q1 24 | — | $8.3M |
| Q4 25 | — | $7.9M | ||
| Q3 25 | — | $8.3M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | — | $8.9M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | — | $8.6M | ||
| Q1 24 | — | $9.1M |
| Q4 25 | $48.2M | $66.7M | ||
| Q3 25 | $52.9M | $66.7M | ||
| Q2 25 | $49.9M | $65.5M | ||
| Q1 25 | $45.2M | $65.9M | ||
| Q4 24 | $43.2M | $67.0M | ||
| Q3 24 | $32.4M | $65.4M | ||
| Q2 24 | $28.6M | $63.7M | ||
| Q1 24 | — | $63.2M |
| Q4 25 | $82.3M | $83.1M | ||
| Q3 25 | $82.3M | $87.1M | ||
| Q2 25 | $78.5M | $83.2M | ||
| Q1 25 | $73.9M | $83.1M | ||
| Q4 24 | $73.4M | $85.6M | ||
| Q3 24 | $61.6M | $89.3M | ||
| Q2 24 | $91.5M | $82.6M | ||
| Q1 24 | — | $80.6M |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.13× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $669.0K |
| Free Cash FlowOCF − Capex | $1.6M | $-2.5M |
| FCF MarginFCF / Revenue | 17.8% | -18.6% |
| Capex IntensityCapex / Revenue | 4.4% | 23.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.6M | $462.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | $669.0K | ||
| Q3 25 | $-3.7M | $2.4M | ||
| Q2 25 | $-5.2M | $4.5M | ||
| Q1 25 | $-5.1M | $1.0M | ||
| Q4 24 | $4.0M | $2.2M | ||
| Q3 24 | $4.1M | $2.6M | ||
| Q2 24 | $-3.6M | $5.0M | ||
| Q1 24 | — | $3.9M |
| Q4 25 | $1.6M | $-2.5M | ||
| Q3 25 | $-4.2M | $-1.5M | ||
| Q2 25 | $-5.7M | $3.9M | ||
| Q1 25 | $-5.4M | $538.0K | ||
| Q4 24 | $3.6M | $-3.4M | ||
| Q3 24 | $4.0M | $1.2M | ||
| Q2 24 | $-3.8M | $3.7M | ||
| Q1 24 | — | $3.1M |
| Q4 25 | 17.8% | -18.6% | ||
| Q3 25 | -23.7% | -7.3% | ||
| Q2 25 | -36.2% | 22.4% | ||
| Q1 25 | -53.0% | 3.1% | ||
| Q4 24 | 19.6% | -19.7% | ||
| Q3 24 | 22.4% | 7.1% | ||
| Q2 24 | -28.1% | 19.7% | ||
| Q1 24 | — | 15.5% |
| Q4 25 | 4.4% | 23.7% | ||
| Q3 25 | 2.8% | 19.1% | ||
| Q2 25 | 2.8% | 3.7% | ||
| Q1 25 | 3.0% | 2.8% | ||
| Q4 24 | 2.3% | 32.3% | ||
| Q3 24 | 0.5% | 7.4% | ||
| Q2 24 | 1.3% | 7.4% | ||
| Q1 24 | — | 4.4% |
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | 2.14× | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | 1.03× | ||
| Q3 24 | 1.27× | 2.56× | ||
| Q2 24 | — | 186.59× | ||
| Q1 24 | — | 2.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
SLNG
| Natural Gas Gathering Transportation Marketing And Processing | $11.1M | 84% |
| Other | $1.3M | 10% |
| Services | $897.0K | 7% |
